[go: up one dir, main page]

WO2008093670A1 - ブドウ果皮・種子乳酸菌発酵物、並びにそれを利用した医薬及び食品 - Google Patents

ブドウ果皮・種子乳酸菌発酵物、並びにそれを利用した医薬及び食品 Download PDF

Info

Publication number
WO2008093670A1
WO2008093670A1 PCT/JP2008/051293 JP2008051293W WO2008093670A1 WO 2008093670 A1 WO2008093670 A1 WO 2008093670A1 JP 2008051293 W JP2008051293 W JP 2008051293W WO 2008093670 A1 WO2008093670 A1 WO 2008093670A1
Authority
WO
WIPO (PCT)
Prior art keywords
seed
fermentation product
lactic acid
pharmaceutical agent
grape skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/051293
Other languages
English (en)
French (fr)
Inventor
Takanari Tominaga
Yoshio Kumazawa
Kiichiro Kawaguchi
Takao Mukai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KITASATO UNIVERSITY GRADUATE SCHOOL OF SCIENCE
TK BIO-RESEARCH LABORATORY Co Ltd
Original Assignee
KITASATO UNIVERSITY GRADUATE SCHOOL OF SCIENCE
TK BIO-RESEARCH LABORATORY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KITASATO UNIVERSITY GRADUATE SCHOOL OF SCIENCE, TK BIO-RESEARCH LABORATORY Co Ltd filed Critical KITASATO UNIVERSITY GRADUATE SCHOOL OF SCIENCE
Priority to JP2008556104A priority Critical patent/JP4990297B2/ja
Publication of WO2008093670A1 publication Critical patent/WO2008093670A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/03—Products from fruits or vegetables; Preparation or treatment thereof consisting of whole pieces or fragments without mashing the original pieces
    • A23L19/07—Fruit waste products, e.g. from citrus peel or seeds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Medical Informatics (AREA)
  • Polymers & Plastics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

　本発明は、ブドウの果皮及び種子の少なくともいずれかを利用し、有用なブドウ果皮・種子乳酸菌発酵物を提供すること、また、前記ブドウ果皮・種子乳酸菌発酵物を利用し、II型糖尿病、高脂血症、肥満等のメタボリックシンドローム関連症状を効果的、かつ安全に治療、改善、又は予防することが可能な医薬及び食品、並びに、皮膚の美白・老化防止に効果的、かつ安全な医薬及び食品を提供することを目的とする。即ち、本発明は、ブドウの果皮及び種子の少なくともいずれかを乳酸菌で発酵させて得られることを特徴とするブドウ果皮・種子乳酸菌発酵物、並びに、前記ブドウ果皮・種子乳酸菌発酵物を含む医薬及び食品に関する。
PCT/JP2008/051293 2007-02-01 2008-01-29 ブドウ果皮・種子乳酸菌発酵物、並びにそれを利用した医薬及び食品 Ceased WO2008093670A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008556104A JP4990297B2 (ja) 2007-02-01 2008-01-29 ブドウ果皮・種子乳酸菌発酵物及びそれを利用した医薬

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007022922 2007-02-01
JP2007-022922 2007-02-01

Publications (1)

Publication Number Publication Date
WO2008093670A1 true WO2008093670A1 (ja) 2008-08-07

Family

ID=39673980

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/051293 Ceased WO2008093670A1 (ja) 2007-02-01 2008-01-29 ブドウ果皮・種子乳酸菌発酵物、並びにそれを利用した医薬及び食品

Country Status (2)

Country Link
JP (1) JP4990297B2 (ja)
WO (1) WO2008093670A1 (ja)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010110374A1 (ja) * 2009-03-26 2010-09-30 ビオフェルミン製薬株式会社 血糖降下作用増強剤
JP2010279286A (ja) * 2009-06-04 2010-12-16 Nippon Bio Co Ltd ブドウ発酵物及びその製造方法
JP2011010648A (ja) * 2009-06-04 2011-01-20 Nippon Bio Co Ltd メタボリックシンドローム改善組成物
JP2012515541A (ja) * 2009-01-27 2012-07-12 ネステク ソシエテ アノニム チコリ酸及び／又はその誘導体を含む組成物
JP2012515542A (ja) * 2009-01-27 2012-07-12 ネステク ソシエテ アノニム カフタル酸及び／又はその誘導体を含む組成物
JP2013163643A (ja) * 2010-04-15 2013-08-22 Wamiles Cosmetics Kk ウメ抽出物を含む剤
JP2014504155A (ja) * 2010-11-30 2014-02-20 株式會社アモーレパシフィック 皮膚老化と関連した遺伝子及び皮膚老化を防止する物質をスクリーニングする方法
WO2015002043A1 (ja) * 2013-07-05 2015-01-08 株式会社ヤクルト本社 ペントシジン生成阻害剤
JP2015180221A (ja) * 2008-12-18 2015-10-15 メルシャン株式会社 清涼飲料、ぶどう果皮抽出液及びそれらの製造方法
KR20150135649A (ko) * 2014-05-23 2015-12-03 재단법인 전주농생명소재연구원 항당뇨 및 항고지혈증 활성을 갖는 락토바실러스 브레비스 jb pml-131 균주 및 이의 용도
KR101591978B1 (ko) 2014-05-23 2016-02-05 재단법인 전주농생명소재연구원 항당뇨 및 항고지혈증 활성을 갖는 락토바실러스 브레비스 jb pml-127 균주 및 이의 용도
JP2016113386A (ja) * 2014-12-12 2016-06-23 日本・バイオ株式会社 美白剤及び美白用化粧料
KR20160131019A (ko) * 2014-03-13 2016-11-15 액세스 비지니스 그룹 인터내셔날 엘엘씨 식물 제형의 상승작용적 조합을 통한 트리글리세리드 합성의 억제를 위한 조성물 및 방법
WO2017061353A1 (ja) * 2015-10-08 2017-04-13 株式会社ゲノム創薬研究所 スクロース摂取による血糖値上昇を抑制する物質の評価方法、スクリーニング方法及び製造方法
EP3223841A2 (en) * 2014-11-27 2017-10-04 InQpharm Group Sdn. Bhd. Composition comprising a pentose and polyphenolic compound
KR101841021B1 (ko) 2017-04-06 2018-03-22 한국식품연구원 최종당화산물 저감 활성을 갖는 신규한 락토코쿠스 락티스 균주 및 이의 용도
KR101869739B1 (ko) 2017-06-23 2018-06-21 한국식품연구원 최종당화산물 저감 활성을 갖는 신규한 락토바실러스 펜토서스 균주 및 이의 용도
KR101869740B1 (ko) 2017-06-23 2018-06-21 한국식품연구원 최종당화산물 저감 활성을 갖는 신규한 락토바실러스 파라카제이 균주 및 이의 용도
CN111345345A (zh) * 2018-12-21 2020-06-30 深圳市华大农业应用研究院 戊糖片球菌的用途
CN114191490A (zh) * 2022-01-28 2022-03-18 善恩康生物科技（苏州）有限公司 一种发酵乳杆菌及其产物在抗氧化和抗肿瘤中的应用
KR102414305B1 (ko) 2021-10-22 2022-06-30 주식회사 디캔트 과일 발효산물과 이를 이용한 향장용 조성물
EP4134440A4 (en) * 2020-04-09 2024-04-24 Kabushiki Kaisha Yakult Honsha MALVA SYLVESTRIS FERMENTATION PRODUCT AND USE THEREOF

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5921151B2 (ja) * 2011-11-08 2016-05-24 日本・バイオ株式会社 ヒアルロニダーゼ活性阻害剤
WO2020090321A1 (ja) 2018-10-30 2020-05-07 株式会社村田製作所 熱ショックタンパク質遺伝子発現調整剤、医薬品、化粧品、及び熱ショックタンパク質遺伝子発現調整剤の製造方法
KR102124429B1 (ko) * 2019-03-12 2020-06-18 김상욱 주류 생산 부산물의 발효, 추출방법 및 상기 방법에 의한 추출물을 포함하는 미백, 주름 개선 및 항노화용 조성물
CN110420146A (zh) * 2019-08-30 2019-11-08 湖北省麦诗特生物科技有限公司 一种具有抗衰老功效的葡萄藤发酵产物提取物的制备方法及应用
JPWO2021059986A1 (ja) 2019-09-25 2021-04-01
EP4162926A4 (en) * 2020-06-08 2024-04-24 Sang Wook Kim METHOD FOR EXTRACTING AN EXTRACT FROM A LYE PRODUCTION BY-PRODUCT AND COMPOSITION FOR BLEACHING, WRINKLE IMPROVEMENT AND ANTI-AGEING CONTAINING THE EXTRACT ACCORDING TO THE METHOD

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001072583A (ja) * 1999-09-07 2001-03-21 Sunstar Inc 高脂血症の予防又は治療用組成物
JP4726022B2 (ja) * 2000-03-28 2011-07-20 キッコーマン株式会社 抗アレルギー、抗炎症剤並びにこれを含有する医薬組成物、医薬部外品、化粧品、食品及び動物用飼料
JP2001346537A (ja) * 2000-06-07 2001-12-18 Sansei Shokuhin Kk 果実外皮を用いた機能性食品およびその製造方法
JP2004187672A (ja) * 2002-11-29 2004-07-08 Toyo Shinyaku:Kk 果物外皮を含む発酵物の製造方法
JP4537024B2 (ja) * 2003-08-06 2010-09-01 株式会社琉球バイオリソース開発 炎症疾患予防・治療剤
JP2005210909A (ja) * 2004-01-27 2005-08-11 Kikkoman Corp 美白健康飲食品
JP4729660B2 (ja) * 2005-01-07 2011-07-20 株式会社 シードライフテック ブドウ種子を原材料としたポリフェノールの製造方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
KEREM Z. ET AL.: "Antioxidant activity and inhibition of alpha-glucosidase by trans-resveratrol, piceid, and a novel trans-stilbene from the roots of Israeli Rumex bucephalophorus L", J. AGRIC. FOOD CHEM., vol. 54, no. 4, 2006, pages 1243 - 1247, XP009158110, DOI: doi:10.1021/jf052436+ *
OHGUCHI K. ET AL.: "Inhibitory effects of resveratrol derivatives from dipterocarpaceae plants on tyrosinase activity", BIOSCI. BIOTECHNOL. BIOCHEM., vol. 67, no. 7, 2003, pages 1587 - 1589, XP007906064, DOI: doi:10.1271/bbb.67.1587 *
SU H.C. ET AL.: "Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats", AM. J. PHYSIOL. ENDOCRINOL. METAB., vol. 290, no. 6, 2006, pages E1339 - E1346 *
YUNOKI K.: "Aka Wine no Alcohol Hakko to Nyusan Hakko Katei deno Resveratrol Kanren Busshitsuryo no Henka", NIPPON SHOKUHIN KAGAKU KOGAKU KAISHI, vol. 51, no. 5, 2004, pages 274 - 278 *

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6087044B2 (ja) * 2008-12-18 2017-03-01 メルシャン株式会社 清涼飲料、ぶどう果皮抽出液及びそれらの製造方法
JP2015180221A (ja) * 2008-12-18 2015-10-15 メルシャン株式会社 清涼飲料、ぶどう果皮抽出液及びそれらの製造方法
JP2012515541A (ja) * 2009-01-27 2012-07-12 ネステク ソシエテ アノニム チコリ酸及び／又はその誘導体を含む組成物
JP2012515542A (ja) * 2009-01-27 2012-07-12 ネステク ソシエテ アノニム カフタル酸及び／又はその誘導体を含む組成物
WO2010110374A1 (ja) * 2009-03-26 2010-09-30 ビオフェルミン製薬株式会社 血糖降下作用増強剤
JP2010248185A (ja) * 2009-03-26 2010-11-04 Biofuerumin Seiyaku Kk 血糖降下作用増強剤
US8889375B2 (en) 2009-03-26 2014-11-18 Biofermin Pharmaceutical Co., Ltd. Hypoglycemic effect enhancer
JP2010279286A (ja) * 2009-06-04 2010-12-16 Nippon Bio Co Ltd ブドウ発酵物及びその製造方法
JP2011010648A (ja) * 2009-06-04 2011-01-20 Nippon Bio Co Ltd メタボリックシンドローム改善組成物
JP2013163643A (ja) * 2010-04-15 2013-08-22 Wamiles Cosmetics Kk ウメ抽出物を含む剤
JP2014504155A (ja) * 2010-11-30 2014-02-20 株式會社アモーレパシフィック 皮膚老化と関連した遺伝子及び皮膚老化を防止する物質をスクリーニングする方法
CN105358165A (zh) * 2013-07-05 2016-02-24 株式会社益力多本社 戊糖素生成抑制剂
JPWO2015002043A1 (ja) * 2013-07-05 2017-02-23 株式会社ヤクルト本社 ペントシジン生成阻害剤
WO2015002043A1 (ja) * 2013-07-05 2015-01-08 株式会社ヤクルト本社 ペントシジン生成阻害剤
US10426804B2 (en) 2013-07-05 2019-10-01 Kabushiki Kaisha Yakult Honsha Pentosidine production inhibitor
KR102263330B1 (ko) * 2014-03-13 2021-06-14 액세스 비지니스 그룹 인터내셔날 엘엘씨 식물 제형의 상승작용적 조합을 통한 트리글리세리드 합성의 억제를 위한 조성물 및 방법
KR20160131019A (ko) * 2014-03-13 2016-11-15 액세스 비지니스 그룹 인터내셔날 엘엘씨 식물 제형의 상승작용적 조합을 통한 트리글리세리드 합성의 억제를 위한 조성물 및 방법
KR101581826B1 (ko) 2014-05-23 2016-01-21 재단법인 전주농생명소재연구원 항당뇨 및 항고지혈증 활성을 갖는 락토바실러스 브레비스 jb pml-131 균주 및 이의 용도
KR101591978B1 (ko) 2014-05-23 2016-02-05 재단법인 전주농생명소재연구원 항당뇨 및 항고지혈증 활성을 갖는 락토바실러스 브레비스 jb pml-127 균주 및 이의 용도
KR20150135649A (ko) * 2014-05-23 2015-12-03 재단법인 전주농생명소재연구원 항당뇨 및 항고지혈증 활성을 갖는 락토바실러스 브레비스 jb pml-131 균주 및 이의 용도
EP3223841A2 (en) * 2014-11-27 2017-10-04 InQpharm Group Sdn. Bhd. Composition comprising a pentose and polyphenolic compound
JP2016113386A (ja) * 2014-12-12 2016-06-23 日本・バイオ株式会社 美白剤及び美白用化粧料
JPWO2017061353A1 (ja) * 2015-10-08 2018-08-30 株式会社ゲノム創薬研究所 スクロース摂取による血糖値上昇を抑制する物質の評価方法、スクリーニング方法及び製造方法
WO2017061353A1 (ja) * 2015-10-08 2017-04-13 株式会社ゲノム創薬研究所 スクロース摂取による血糖値上昇を抑制する物質の評価方法、スクリーニング方法及び製造方法
KR101841021B1 (ko) 2017-04-06 2018-03-22 한국식품연구원 최종당화산물 저감 활성을 갖는 신규한 락토코쿠스 락티스 균주 및 이의 용도
KR101869739B1 (ko) 2017-06-23 2018-06-21 한국식품연구원 최종당화산물 저감 활성을 갖는 신규한 락토바실러스 펜토서스 균주 및 이의 용도
KR101869740B1 (ko) 2017-06-23 2018-06-21 한국식품연구원 최종당화산물 저감 활성을 갖는 신규한 락토바실러스 파라카제이 균주 및 이의 용도
CN111345345A (zh) * 2018-12-21 2020-06-30 深圳市华大农业应用研究院 戊糖片球菌的用途
EP4134440A4 (en) * 2020-04-09 2024-04-24 Kabushiki Kaisha Yakult Honsha MALVA SYLVESTRIS FERMENTATION PRODUCT AND USE THEREOF
KR102414305B1 (ko) 2021-10-22 2022-06-30 주식회사 디캔트 과일 발효산물과 이를 이용한 향장용 조성물
CN114191490A (zh) * 2022-01-28 2022-03-18 善恩康生物科技（苏州）有限公司 一种发酵乳杆菌及其产物在抗氧化和抗肿瘤中的应用

Also Published As

Publication number Publication date
JP4990297B2 (ja) 2012-08-01
JPWO2008093670A1 (ja) 2010-05-20

Similar Documents

Publication Publication Date Title
WO2008093670A1 (ja) ブドウ果皮・種子乳酸菌発酵物、並びにそれを利用した医薬及び食品
WO2009069498A1 (ja) 乳酸菌の生残性向上剤及び生残性向上方法、並びに食品組成物
WO2012060579A3 (ko) 항균용 유산균 사균체 및 이의 제조방법
NZ598950A (en) Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
MY172363A (en) Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof
WO2008108298A1 (ja) 内臓脂肪減少剤
NZ596788A (en) Use of selected lactic acid bacteria for reducing infantile colic
UA101316C2 (ru) Применение отобранных молочнокислых бактерий для профилактики и лечения атеросклероза
MX389027B (es) Tratamiento del tabaco.
WO2011162523A3 (ko) 쌍화탕 또는 이의 유산균 발효물을 포함하는 골다공증 예방 또는 치료용 조성물
MX337716B (es) Preparacion que contiene bacteria de acido lactico.
WO2010127155A3 (en) Inhibition of pathogenic growth on plant materials using lactic acid producing microorganisms
WO2008073841A3 (en) Lactobacillus buchneri strain ln1297 and its use to improve aerobic stability of silage
WO2013058594A3 (ko) 항염 활성을 갖는 발효녹용 추출물의 제조 방법, 이로부터 얻어진 추출물 및 이러한 추출물의 용도
EP2727994A4 (en) NEW MILKY ACID BACTERIUM AND METHOD FOR PRODUCING A SILAGE OR A FERMENTED FUTTER THEREFOR
ATE551419T1 (de) Bakterienstamm mit antiallergischer aktivität sowie getränk, lebensmittel und antiallergikum mit zelle des bakterienstamms
MX2009008045A (es) Metodo para producir acido lactico mediante la fermentacion de un medio autosuficiente que contiene jugo de caña en bruto.
WO2010088450A3 (en) Arylamide derivatives useful in the treatment of diseases associated with serca activity
WO2008073853A8 (en) Lactobacillus buchneri strain ln5689 and its use to improve aerobic stability of silage
WO2008073839A3 (en) Lactobacillus buchneri strain ln1286 and its use to improve aerobic stability of silage
MX2012007970A (es) Proceso para la preparacion de una biomasa que comprende plantaricina y usos de la misma en el campo medico.
WO2008105540A1 (ja) アレルギー疾患及び自己免疫疾患に有効な医薬及び食品
WO2008123128A1 (ja) アディポネクチン産生促進剤
PL2224820T3 (pl) Produkty żywnościowe
WO2011126342A3 (ko) 대잎둥굴레 또는 층층갈고리둥굴레 추출물의 신규한 용도

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08710620

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2008556104

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08710620

Country of ref document: EP

Kind code of ref document: A1